Arteric Technology Utilized in Hypertension Medication Adherence Study at Baylor College of Medicine

OnTimeRx® Automated Reminder Service Tested in Stroke Prevention Program Targeting African-American Women

Arteric is a digital agency, but ultimately, we’re in the life extension business. By blending exceptional software development skills with healthcare marketing expertise, we help brands and healthcare organizations connect patients, caregivers and healthcare professionals with the health information and tools they need to live longer, healthier lives.

Susan Torrico, a career pharmacist and medication-adherence pioneer, is also in the life extension business. In 2000, after watching too many patients lose their transplanted organs because they didn’t follow their anti-rejection treatment regimens, Susan began experimenting with mobile technology as a method to improve medication adherence. As Susan explains, “It was devastating seeing so many people, especially teens, miss out on an opportunity for a healthier life simply because they didn’t take their medication. At that point, I developed the concept that became OnTimeRx®.”

In 2005, Arteric teamed up with Susan to develop the OnTimeRx® Automated Reminder Service — mobile technology that provides Web-based reminder-scheduling and notification messages that are delivered by text message, phone call or email. The Automated Reminder Service is the most recent addition to the OnTimeRx® adherence software collection, which include apps for the iPhone® and iPad®, for Android smartphones, and for Windows® desktop computers. These software apps provide reminders in the form of alarm sounds and/or on-screen notices as an alternative to text messages, phone calls or email.

We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population. Preliminary results from a very small patient population look promising.

In addition to transplant patients, OnTimeRx® technology has been applied in adherence studies involving HIV treatment in young people. It was inspiring to learn that OnTimeRx® software is now being evaluated in a population at risk for hypertension.1 African-American women are more prone to hypertension than non-African Americans — 47.5% vs 28%.2,3 Medication non-adherence can cause these women to develop a decreased threshold for stroke development or an increased progression of cardiovascular disease.

To address this issue, researchers at the Baylor College of Medicine are implementing the OnTimeRx® Automated Reminder Service in a pilot study investigating the efficacy of smartphone-based services to improve medication adherence.4 The study is funded by The Lone Star Stroke Consortium, which is a Texas-based collaboration of major stroke centers, and the Texas Nursing Association-District 9.

Study researcher Vanessa Monroe, Clinical Assistant Professor at Prairie View A&M University College of Nursing and PhD Candidate at Texas Woman’s University-Houston, shared these thoughts with us. “We’re very interested in determining if the automated phone and email reminders sent by OnTimeRx® improve medication adherence in this at-risk population.” Vanessa continued, “Preliminary results from a very small patient population look promising. We’re in the midst of adding more patients to the study.”

We’ll keep you informed about Vanessa’s progress, because non-adherence remains a vexing challenge, with rates ranging from 30% to 60% depending on the condition, the treatment, the patient and the setting.4 Medication error rates are just as worrisome — 20% to 80% of patients make mistakes and up to 60% of patients stop their medication too soon.Non-adherence also creates an economic burden. The cost of drug-related morbidity and mortality in the ambulatory setting in the United States has been estimated to be as high as $136 billion.5

Nonadherence has many contributing factors, and so presents a moving target. But mobile communication technology is continually evolving, and we’re evolving our platforms and extending OnTimeRx® functionality to help patients and healthcare providers meet the challenge.


Software solutions  from apps to enterprise

Arteric connects patients, caregivers, and healthcare professionals to the health information they need to live longer, healthier lives. We achieve this by finding and filling unmet needs with intuitive well designed technologies. However needs change and technology evolves, count on Arteric to combine infinite curiosity, what if? thinking and unstoppable software expertise to develop life-changing custom mobile apps and out-of-the-box-ready enterprise solutions for pharma, biotech and life science marketers and the people that they help

For information about OnTimeRx® products, contact Jon Fisher at 201.546.9902.
For information about the clinical trial, contact Vanessa Monroe at 832.971.8682.

OnTimeRx is a registered trademark of Arteric.
Windows is a trademark of Microsoft Corporation                                             iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google Inc.


  1. Monroe V, Dello Stritto R, Langford R, Young A. (2017). Texas Woman’s University-Houston. Testing a Smartphone Application Intervention to Improve Medication Adherence in African American Female Clinic Patients with Unstable High Blood Pressure: A Two Group Randomized Control Trial. Presented at the Southern Nurse Research Society Symposium. Dallas, Texas.
  2. Taylor J, Peternell B, Smith J. (2013). Attitudes toward genetic testing for hypertension among African American women and girls. Nurs Res Pract. 2013;2013:341374. doi:10.1155/2013/341374 
  3. Still C, Craven T, Freedman B, et al. (2015). Baseline characteristics of African Americans in the systolic blood pressure intervention trial. J Am Soc Hypertens. 2015;9(9), 670-679. doi:10.1016/j.jash.2015.06.012
  4. Gottlieb H. Medication Nonadherence: Finding Solutions to a Costly Medical Problem. Medscape. Available at Accessed May 3, 2017.
  5. Johnson J, Bootman J. (1995) Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med (18):1949-56.

Arteric President and Founder Hans Kaspersetz Featured in Life Science Marketing Podcast

Veteran SEO Speaker and Panelist Discusses Foundational and Leading-Edge SEO Tactics for Life Science and Biotech Marketers

SUMMIT, N.J., April 28, 2017 — Arteric (, a digital healthcare marketing agency that fuses exceptional software development skill with healthcare marketing expertise to help brands connect patients, caregivers and healthcare professionals with the health information they need to live longer, healthier lives announced today that Life Science Marketing Radio, the pre-eminent podcast for life science marketers, published How to Establish Authority by Helping Google Understand Your Niche, presented by Arteric President and founder Hans Kaspersetz.

We need to be thinking about where our users will be down the road, in six months, 12 months, 18 months, and where we think Google’s going to be down the road, in six months, 12 months, 18 months. Then, we need to build content strategies that look that far out.

Following the recording of the radio show, Mr. Kaspersetz said, “Connecting laboratory scientists, clinical research teams, students and clinicians with information about protocols, equipment, reagents, scholarly work and all the other components of their research accelerates discoveries and drives profits for the businesses supporting them. We are driven by the fact that their primary research is transformative and leads to people living longer, healthier lives.”

Mr. Kaspersetz continued, “Digital strategy, content strategy, Web publishing and search engine optimization are essential to breaking through the confusion and noise online and delivering a clear, persuasive educational signal. We’ve been fortunate at Arteric to educate brands, researchers, clinicians and scientists on how to achieve remarkable results online. Our techniques work in pharma, biotech, life science and advocacy communication that requires the marriage of high science and technology. We believe that information should be democratized. Sharing our two decades of Web development and SEO wisdom is the core of our beliefs.”

How do we tell better stories? How do we satisfy users’ query intent more accurately? The best place to start is to see what people are actually searching for.

Chris Conner, founder of Life Science Marketing Radio and former head of global marketing communication for life science instrumentation companies, cites the demand for SEO strategy. “When I led marketing communication teams, I saw the impact of thorough, research-driven SEO and SEM strategies. I also observed the limitations of incomplete SEO, which is why I’m anxious to share Hans’s 360-degree approach to leveraging and applying search engine research.”

Mr. Kaspersetz adds, “Supporting the efforts of the life science community is a natural progression for a healthcare agency like Arteric. As a member of the board of directors for an organization that’s advancing the application of personalized medicine, I see how rapidly research tools like genetic analysis technologies are entering clinical use.”

If you would like to connect with Hans Kaspersetz about your brand or digital communication needs, you can find him at:

  • MM&M Awards, New York, October 2017 — Mr. Kaspersetz is an in-person juror
  • ASCO, Chicago, June 2017 — Mr. Kaspersetz is an invited Coach at Celgene Patient Partners Learning Labs
  • Digital Pharma West, San Francisco, June 2017
  • Digital Pharma East, Philadelphia, October 2017
  • PubCon, Las Vegas, November 2017

Listen to the podcast here:


Blogs Don’t Draw Traffic, Content Draws Traffic

Blogs Don't Attract Traffic, Content Does

Recently, I delivered the second in a series of webinars for patient advocacy groups on how to increase traffic. The title of the webinar was Breaking Through the Clutter to Inform Your Audience. This webinar focused on content marketing and content management for patient advocacy.

The presentation covered fundamental content marketing ideas, such as:

  • Alignment of the corporate mission with the editorial mission
  • Alignment of the editorial mission with key measures of success
  • Technical content management and production guidelines for search engine performance

My main thrust was to provide a set of guidelines for evaluating the audience’s content-marketing maturity and evolving their content strategy. My hope was that they would be emboldened to make the hard decisions necessary to focus on their niche and to improve the depth and quality of their content so that they can achieve greater audience engagement.

After the presentation, I was asked,

Do blogs help advocacy organizations drive more people to their Web site, and if so, how?

A nice jargon-filled answer that breaks the rules of content marketing is:

“Yes, a narrowly targeted blog that has high-quality, semantically dense, holistic content and has installments published on a regular basis and that is supported by a multichannel promotional effort will draw traffic and engage the audience.”

However, I think that the question may miss the mark. A blog is a publishing channel. It is a technology and thus will not draw traffic on its own. The choice to use a blog to distribute your organization’s content should be made only after you have developed a content-marketing strategy that includes longer-form content that is published on a temporal basis and after you’ve decided that you will leverage other channels, such as social media, video, or offline events to promote the blog. Blogs don’t draw traffic, content draws traffic.

“Blogs don’t draw traffic, content draws traffic.”

After we ponder the question a bit, it becomes clear that we need to answer some fundamental questions. I want to share some of our thinking on how we approach content strategy.

Questions to Shape Content Marketing Strategy

  • What is our corporate mission?
  • What is our editorial mission?
  • What are our most important goals? (fundraising, engagement, volunteerism?)
  • For whom we publishing for?
  • What do we want our audience to do?
  • How will we know whether we are being successful? What should we measure?
  • What is our budget?
  • What resources can we commit to publishing? Over what period of time?
  • Do we have the expertise to create the content at a sufficient level of quality and depth to compete and rank?
  • Have we looked at the sites listed in the search results that we are targeting?
  • Is there really a need in the market for us to publish on this topic?

If you use melanoma as an example, your answers may sound like this:

Our mission is to publish medical information about melanoma for patients and caregivers.  Our goal is to educate people on the prevention of melanoma and, in the unfortunate event of a diagnosis, to guide people to the most effective available treatment, so that they can stop the progression of their disease and possibly achieve remission.

Our corporate and editorial missions dictate that engagement is our most important goal. So we measure and analyze time on site, number of pages viewed, and unique visitors.

We have a sophisticated budgeting process and have an established annual budget that supports multiple content team members. So we organize the team’s effort and investment to advance toward our written goals.

Finally, there are no other Web sites publishing content with the quality that we will achieve on the topics for which we have the deepest expertise.

While this scenario is an ideal example, achieving this level of finish is a lofty goal that most advocacy groups will not reach.

Creating the Content

Answering the questions above will create the foundation needed to determine your effective strategy.  We decided that our most effective strategy will be to identify topics that would benefit our audience and provide enough information if articles are at least 1200 words long.

Example Image of What 1200 Words Look Like
Effective content for a patient advocacy blog should be roughly 1200 words.

We will ignore the technology as we develop the articles. Then we can put the information on the platform that best suits our strategy. The articles will be highly structured so that sections can be broken up into lists, quotes, infographics, and paragraphs that can stand together or on their own, depending on how we disseminate the content.

Image of well structured content
Structured content is a strong quality signal.

The final draft of each article that we produce, should be written by a professional writer and edited by professional proofreader. The content will be supported by infographics that help convey important information.

Now that the content has been developed we must identify the optimal channel.

Our avenue for publishing may include any of the following: our Web site; our blog; a traditional journal, periodical, or news outlet; an allied publication; a video; a podcast; or a webinar.

Possible channels for distributing content.
Possible channels for distributing content.

Promoting Your Content

To maximize your investment, you must plan the timing of your published content and sharing of your content with news cycles, seasons, or relevant current events to increase traffic.

Once we choose the outlet and the ideal publishing date, we plan our social media and promotional strategy. Social promotion may include teasers to Facebook and Twitter. Making the most out of the content, we also publish the infographics to Instagram or Pinterest.

This effort creates awareness of the article with our audiences and key influencers/connectors.

In order for us to understand which channels are best, we actively monitor their performance.  Our future focus will be on the most productive channels. We will ignore the unproductive channels.

Durable content is created that remains relevant for readers is called evergreen content. When articles fall into this category, we will repeat the promotional efforts every few months or in response to currently trending topics.

Reusing evergreen content will significantly increase the ROI/ROE per article. We can even substitute an old article into the cycle if there is a shortage of topics to publish about.

The key idea is that we created a content asset that can be used in many different ways. We broke it down into reusable components, we published the main asset on our blog, and we used the component pieces across promotional channels to draw the audience into the main asset. We measured as much as we could, and we evaluated the results in the context of our editorial mission and our corporate mission. Through this process, we gained important insights, which then inspired new content and helped to direct our future investments.

Competitive Advantage in Content Marketing

This example is very sophisticated. Fewer than 4% of nonprofits report achieving this level of planning, integration, and execution.

Image Results of Non Profit's Self-Assessment of Their Content Marketing Maturity
Source: 2016 Nonprofit Content Marketing Trends—North America: Content Marketing Institute/Blackbaud/

This is great news. It means that you do not have to be perfect at content marketing to compete and win your audience. Your organization will be measured along a continuum of content-marketing maturity, and your operational excellence will vary over time. If you take the time to answer the questions I listed above, your performance will likely improve significantly and you will outperform your competitors. You will achieve greater ROI and improve on your key measures of success, whether they be engagement or fundraising.

“Just start, and then build the momentum.”

My advice is to just start, and then build on the momentum. If you are not sure where to start, call Arteric. We will be happy to answer your questions and help you evolve your content-marketing strategy in order to advance your goals.


Fast-growing pharmaceutical and biotechnology digital agency broadens its digital healthcare capabilities with 15-year veteran.

Summit, NJ ( Arteric ( is pleased to announce that Jon Fisher has joined the company as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency.

Jon has played a key role in the development of digital strategy for multiple pharmaceutical companies, including Gilead, Astra Zeneca, Boehringer Ingelheim, Celgene, Alkermes, Biogen, Abbott, and others across many brands, from pre-launch to full promotional launch.

Jon is well versed in the development of Web sites, customer relationship management programs, mobile apps, e-commerce sites, and digital tactics across the board. Jon is always looking for innovative yet practical solutions to problems in the healthcare environment, while always keeping the end users in mind.

Hans Kaspersetz, co-Founder and President of Arteric, comments:

“As Arteric grows, it’s essential for our teams to have the appropriate mix of skills and experience necessary to grow our business for the long term, and Jon certainly brings that mix.”

Jon has experience across an array of therapeutic categories, including cardiology, dermatology, endocrinology, infectious disease, psychiatry, and rheumatology. He says,

“I’m excited to join the team at Arteric. Because of my wealth of experience in digital solutions for so many therapeutic categories, I can help Arteric deliver top-quality work to our clients.”

Jon is from upstate New York, has a passion for travel, and lives by the motto “try anything once.”

About Arteric

Arteric is a digital agency for pharmaceutical and biotechnology brands. Arteric has leading-edge expertise in launching new drug brands and growing corporate brands. Arteric creates inspiring strategies and technologies that improve peoples’ lives.

Why Arteric Attended South by South West (SXSW), and Why You Should, Too

SXSW is an annual set of film, interactive media, music festivals and conferences that take place in mid-March in Austin, Texas. It sounds like great fun, and it is. So how can you persuade your manager to approve a trip like that? At Arteric, we decided that sending a team to SXSW made good business sense. Arteric team members would see new technologies and digital health advancements and network with prospective clients.

Yet after going to SXSW, we came up with even more reasons for going next year. Any company that creates software and content, or that designs and builds experiences would be smart to send a team to SXSW. The ROI is hard to quantify, but SXSW exposes individuals to real, practical uses of new technology. Seeing, hearing, and interacting with these technologies in person is inspirational. This first-hand experience is the only way to truly understand how these technologies can improve our lives.

Inspire Passion and Creativity, and Encourage Action

At Arteric, we are passionate about the potential of technology to improve health. Sending a team to SXSW encourages the passionate conversations to continue beyond each session. New ideas can be debated and discussed and new courses of action can be created.

During every meal we had at SXSW, the conversations were about new technologies and ideas we saw or heard about during the day. That is exactly what we want at Arteric. We want to foster creativity and curiosity to explore something new, not just for Arteric but for our clients. In the past, we had debated a lot about virtual reality and how applicable it can be for digital health; but after experiencing virtual reality at the Samsung exhibit, we came back to New Jersey with 3 Samsung Gear headsets.

Jon Fisher, our director of technology, trying out the new Samsung Gear VR headset at SXSW 2016.
Jon Fisher, our Director of Technology, trying out the new Samsung Gear VR headset at SXSW 2016.

Arteric sent several people to SXSW, so that we could cover a wider array of amazing presentations. Arteric team members attended sessions on new perspectives for recruiting, on designing for environments without a smart screen, and on data sharing from Google’s self-driving cars. We also saw the first-time demo of the Meta 2 AR headset.

Experience & Explore New Opportunities

Over 70,000 people register for SXSW, which makes it a prime venue for companies to demonstrate and sell new products. Roughly 300 vendors had booths at the SXSW convention center. This gave the Arteric team the opportunity to explore new software that could improve efficiencies, as well as seeing new technology in use, like this cool Grid Vrick that comes out of Korea. 

Yet SXSW is not confined to the convention center. All over Austin are pop-up locations that provide insight into future technologies. At the 2016 SXSW, we saw Google’s Tilt Brush, Samsung’s VR Experience, IBM’s Watson, and Krush’s Virtual Reality flight simulator.

Virtual Reality drawing. Demonstration of Tilt Brush software at Google Fiber in Austin, TX during SXSW 2016.
Virtual Reality drawing. Demonstration of Tilt Brush software at Google Fiber in Austin, TX during SXSW 2016.
President of Arteric interacting with IBM Watson at SXSW 2016.
Arteric President Hans Kaspersetz interacting with IBM’s Watson at SXSW 2016.

Team Bonding

There is no way to calculate the ROI for team bonding. But traveling together and spending downtime create a camaraderie that improves team performance in the office. It builds trust and encourages more open communication between team members.



Arteric’s Coverage from SXSW 2016

Arteric’s Coverage of ePharma 2016 – New York, New York